International audienceWe present a new covariate-adjusted response-adaptive randomized controlled trial design and inferential procedure built on top of it. The procedure is targeted in the sense that {\em (i)} the sequence of randomization schemes is group-sequentially determined by targeting a user-specified optimal randomization design based on accruing data and, {\em (ii)} our estimator of the user-specified parameter of interest, seen as the value of a functional evaluated at the true, unknown distribution of the data, is targeted toward it by following the paradigm of targeted minimum loss estimation. We focus for clarity on the case that the parameter of interest is the marginal effect of a binary treatment and that the targeted opti...
In randomized trials, pair-matching is an intuitive design strategy to protect study validity and to...
Covariate adjustment using linear models for continuous outcomes in randomized trials has been shown...
The conduct of a traditional, equally randomized clinical trial may sacrifice patient benefit by equ...
Adaptive clinical trial design methods have garnered growing attention in the recent years, in large...
Adaptive clinical trial design methods have garnered growing attention in the recent years, in large...
In randomized experiments, linear regression is often used to adjust for imbalances in covariates be...
This article is devoted to the construction and asymptotic study of adaptive group sequential covar...
We provide a principled way for investigators to analyze randomized experiments when the number of c...
The development of targeted therapy involve many challenges. Our study will address some of the key ...
This article is devoted to the asymptotic study of adaptive group sequential designs in the case of ...
International audienceThis article is devoted to the construction and asymptotic study of adaptive g...
In many randomized and observational studies the allocation of treatment among a sample of n indepen...
Since Food and Drug Administration (FDA) issued the very first draft guidance in 2010, adaptive desi...
This article is devoted to the asymptotic study of adaptive group sequential designs in the case o...
International audienceThis article is devoted to the asymptotic study of {\em adaptive group sequent...
In randomized trials, pair-matching is an intuitive design strategy to protect study validity and to...
Covariate adjustment using linear models for continuous outcomes in randomized trials has been shown...
The conduct of a traditional, equally randomized clinical trial may sacrifice patient benefit by equ...
Adaptive clinical trial design methods have garnered growing attention in the recent years, in large...
Adaptive clinical trial design methods have garnered growing attention in the recent years, in large...
In randomized experiments, linear regression is often used to adjust for imbalances in covariates be...
This article is devoted to the construction and asymptotic study of adaptive group sequential covar...
We provide a principled way for investigators to analyze randomized experiments when the number of c...
The development of targeted therapy involve many challenges. Our study will address some of the key ...
This article is devoted to the asymptotic study of adaptive group sequential designs in the case of ...
International audienceThis article is devoted to the construction and asymptotic study of adaptive g...
In many randomized and observational studies the allocation of treatment among a sample of n indepen...
Since Food and Drug Administration (FDA) issued the very first draft guidance in 2010, adaptive desi...
This article is devoted to the asymptotic study of adaptive group sequential designs in the case o...
International audienceThis article is devoted to the asymptotic study of {\em adaptive group sequent...
In randomized trials, pair-matching is an intuitive design strategy to protect study validity and to...
Covariate adjustment using linear models for continuous outcomes in randomized trials has been shown...
The conduct of a traditional, equally randomized clinical trial may sacrifice patient benefit by equ...